跳至主要内容
临床试验/ChiCTR2000038120
ChiCTR2000038120尚未招募Unknown

Use of magnetic tracer for sentinel lymph node biopsy in breast cancer is non inferior to the standard dual tracers technique: A multi-center non-inferior randomized trial

Sponsored by endomagnetic limited2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2020年11月2日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
300
试验地点
2
主要终点
Identification rate of SLN

研究概览

简要总结

Compare the identification rate between SPIO and standard dual tracers technique used in sentinel lymph node biopsy in breast cancer patients.

研究设计

研究类型
Interventional
主要目的
整群随机分组
盲法
N/a

入排标准

性别
Male

入选标准

  • Patient with breast cancer scheduled to have SLNB and who are clinically and radiologically node negative

排除标准

  • Patient treated with neoadjuvant chemotherapy, history of axillary radiation, history of ipsilateral axillary surgery; non palpable breast cancer requiring simultaneous localization; patient with known intolerance or hypersensitivity to iron or dextran compounds, magnetic tracers or SPIO; with an iron-overload disease; with pacemakers or other implantable devices on the chest wall; with known hypersensitivity to blue dye; who could not or did not receive radioisotope

研究组 & 干预措施

A

Magnetic tracer

B

Dual tracer

结局指标

主要结局

Identification rate of SLN

次要结局

未报告次要终点

研究者

发起方
Sponsored by endomagnetic limited

研究点 (2)

Loading locations...

相似试验